Robert A. Weinstein

44.8k total citations · 12 hit papers
349 papers, 27.9k citations indexed

About

Robert A. Weinstein is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Robert A. Weinstein has authored 349 papers receiving a total of 27.9k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Infectious Diseases, 98 papers in Epidemiology and 72 papers in Molecular Medicine. Recurrent topics in Robert A. Weinstein's work include Antimicrobial Resistance in Staphylococcus (74 papers), Antibiotic Resistance in Bacteria (72 papers) and Antibiotic Use and Resistance (64 papers). Robert A. Weinstein is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (74 papers), Antibiotic Resistance in Bacteria (72 papers) and Antibiotic Use and Resistance (64 papers). Robert A. Weinstein collaborates with scholars based in United States, Netherlands and Japan. Robert A. Weinstein's co-authors include Bala Hota, Mary K. Hayden, Latania K. Logan, Catherine Nathan, L. Silvia Muñoz-Price, E. Patchen Dellinger, Trish M. Perl, Scott K. Fridkin, S. A. Kabins and Marc J. M. Bonten and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert A. Weinstein

335 papers receiving 26.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

2006 2.5k citations Robert A. Weinstein et al. Clinical Infectious Diseases profile →
Clinical practice guidelines for antimicrobial prophylaxis in surgery

2013 1.5k citations Robert A. Weinstein et al. profile →
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

2017 1.1k citations Latania K. Logan, Robert A. Weinstein profile →
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

2013 806 citations Robert A. Weinstein et al. profile →
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities

2006 757 citations Robert A. Weinstein et al. Clinical Infectious Diseases profile →
Guidelines for the Prevention of Intravascular Catheter–Related Infections

2002 662 citations Robert A. Weinstein et al. Infection Control and Hospital Epidemiology profile →
Acinetobacter Infection

2008 582 citations Robert A. Weinstein et al. New England Journal of Medicine profile →
Antibiotic Resistance Among Gram-Negative Bacilli in US Intensive Care Units

2003 539 citations Robert A. Weinstein et al. profile →
Targeted versus Universal Decolonization to Prevent ICU Infection

2013 516 citations Susan S. Huang, Edward Septimus et al. New England Journal of Medicine profile →
Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship

2009 513 citations Bala Hota, Robert A. Weinstein et al. Clinical Infectious Diseases profile →
Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection

2013 412 citations Loreen A. Herwaldt, Robert A. Weinstein et al. New England Journal of Medicine profile →
Effectiveness of Chlorhexidine Bathing to Reduce Catheter-Associated Bloodstream Infections in Medical Intensive Care Unit Patients

2007 235 citations William E. Trick, Mary K. Hayden et al. profile →

Peers

Countries citing papers authored by Robert A. Weinstein

Since Specialization

Citations

This map shows the geographic impact of Robert A. Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Weinstein more than expected).

Fields of papers citing papers by Robert A. Weinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Weinstein. The network helps show where Robert A. Weinstein may publish in the future.

Co-authorship network of co-authors of Robert A. Weinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Weinstein. A scholar is included among the top collaborators of Robert A. Weinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Weinstein. Robert A. Weinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibiotic-resistance plasmid amplified among MRSA cases in an urban jail and its connected communities 2025 ·Nature Communications ·(unknown), (unknown), (unknown), Sarah E. Sansom, Alla Aroutcheva, (unknown), (unknown), (unknown), Ali Pirani, Robert A. Weinstein, (unknown), Nicholas M. Moore, Kyle J. Popovich, Evan S. Snitkin	0
2	The association between prolonged SARS-CoV-2 symptoms and work outcomes 2024 ·PLoS ONE ·Arjun K. Venkatesh, Huihui Yu, (unknown), Michael Gottlieb, Joann G. Elmore, Mandy J. Hill, Ahamed H. Idris, Juan Carlos C. Montoy, Kelli N. O’Laughlin, Kristin L. Rising, Kari A. Stephens, Erica S. Spatz, Robert A. Weinstein, (unknown)	2
3	Random variation drives a critical bias in the comparison of healthcare-associated infections 2023 ·Infection Control and Hospital Epidemiology ·Kenneth J. Locey, Thomas A. Webb, Robert A. Weinstein, Bala Hota, Brian Stein	1
4	Regional Spread of bla NDM-1-Containing Klebsiella pneumoniae ST147 in Post-Acute Care Facilities 2021 ·Clinical Infectious Diseases ·Zena Lapp, Ryan Crawford, (unknown), Ali Pirani, William E. Trick, Robert A. Weinstein, Mary K. Hayden, Evan S. Snitkin, Michael Y. Lin	30
5	Genomic Update of Phenotypic Prediction Rule for Methicillin-Resistant Staphylococcus aureus (MRSA) USA300 Discloses Jail Transmission Networks with Increased Resistance 2021 ·Microbiology Spectrum ·Sarah E. Sansom, (unknown), (unknown), Bala Hota, Alla Aroutcheva, (unknown), (unknown), Evan S. Snitkin, Stefan J. Green, Robert A. Weinstein, Kyle J. Popovich	8
6	A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children 2020 ·Antimicrobial Agents and Chemotherapy ·Latania K. Logan, Liqing Zhang, Stefan J. Green, Samuel Dorevitch, Gustavo Arango-Argoty, (unknown), Emily Garner, Jared Aldstadt, (unknown), Mary K. Hayden, Robert A. Weinstein, Amy Pruden	5
7	Cohorting KPC+ Klebsiella pneumoniae (KPC-Kp)–positive patients: A genomic exposé of cross-colonization hazards in a long-term acute-care hospital (LTACH) 2020 ·Infection Control and Hospital Epidemiology ·(unknown), Mary K. Hayden, Karen Lolans, (unknown), Robert A. Weinstein, Michael Y. Lin, Evan S. Snitkin	3
8	Integrated genomic and interfacility patient-transfer data reveal the transmission pathways of multidrug-resistant Klebsiella pneumoniae in a regional outbreak 2017 ·Science Translational Medicine ·Evan S. Snitkin, Sarah Won, Ali Pirani, Zena Lapp, Robert A. Weinstein, Karen Lolans, Mary K. Hayden	40
9	Evolving Epidemiology ofStaphylococcus aureusBacteremia 2015 ·Infection Control and Hospital Epidemiology ·Yoona Rhee, Alla Aroutcheva, Bala Hota, Robert A. Weinstein, Kyle J. Popovich	46
10	From Albania to Zambia: Travel Back to Country of Origin as a Goal of Care for Terminally Ill Patients 2014 ·Journal of Palliative Medicine ·Catherine Deamant, (unknown), Keiki Hinami, Robert A. Weinstein, William E. Trick	8
11	Targeted versus Universal Decolonization to Prevent ICU Infection breakdown → 2013 ·New England Journal of Medicine ·Susan S. Huang, Edward Septimus, Ken Kleinman, Julia Moody, Jason Hickok, Taliser R. Avery, Julie Lankiewicz, Adrijana Gombosev, Leah Terpstra, (unknown), Mary K. Hayden, John A. Jernigan, Robert A. Weinstein, Victoria J. Fraser, Katherine Haffenreffer, Eric Cui, Rebecca E. Kaganov, Karen Lolans, Jonathan B. Perlin, Richard Platt	516
12	Notes from the Decennial 2010 ·American Journal of Infection Control ·Robert A. Weinstein, (unknown), Sanjay Saint, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
13	Why Don't They Listen? Adherence to Recommendations of Infectious Disease Consultations 2004 ·Clinical Infectious Diseases ·(unknown), Katayoun Rezai, Arthur T. Evans, Miguel G. Madariaga, Michael Phillips, (unknown), David N. Schwartz, Yiting Wang, Robert A. Weinstein, Gordon M. Trenholme	46
14	Controlling Antimicrobial Resistance in Hospitals: Infection Control and Use of Antibiotics 2001 ·SHILAP Revista de lepidopterología ·Robert A. Weinstein	18
15	A New Preadmission Staging System for Predicting Inpatient Mortality from HIV-associated Pneumocystis carinii Pneumonia in the Early Highly Active Antiretroviral Therapy (HAART) Era 2000 ·American Journal of Respiratory and Critical Care Medicine ·Ahsan M. Arozullah, Paul R. Yarnold, Robert A. Weinstein, (unknown), (unknown), Joan S. Chmiel, (unknown), Cheeling Chan, Matthew Bidwell Goetz, David N. Schwartz, Charles L. Bennett	39
16	Improvements in Outcomes of Acute Respiratory Failure for Patients with Human Immunodeficiency Virus-related Pneumocystis carinii Pneumonia 2000 ·American Journal of Respiratory and Critical Care Medicine ·J. Randall Curtis, Paul R. Yarnold, David N. Schwartz, Robert A. Weinstein, Charles L. Bennett	70
17	Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia 1998 ·Critical Care Medicine ·J. Randall Curtis, Charles L. Bennett, Ronnie D. Horner, Gordon D. Rubenfeld, Jack DeHovitz, Robert A. Weinstein	25
18	Relationship Between Procedures and Health Insurance for Critically Ill Patients With Pneumocystis Carinii Pneumonia 1995 ·American Journal of Respiratory and Critical Care Medicine ·Ronnie D. Horner, Charles L. Bennett, Daniel Rodríguez, Robert A. Weinstein, Harold A. Kessler, Gordon M. Dickinson, Jason L. Johnson, Susan E. Cohn, W. Lance George, Stuart C. Gilman	40
19	A Rapid Preadmission Method for Predicting Inpatient Course of Disease for Patients with HIV-Related Pneumocystis Carinii Pneumonia 1994 ·American Journal of Respiratory and Critical Care Medicine ·C. L. Bennett, Robert A. Weinstein, Martin F. Shapiro, Harold A. Kessler, Gordon M. Dickinson, B. A. Peterson, Susan E. Cohn, W. Lance George, Stuart C. Gilman	37
20	OSHA Bloodborne Hazard Standard 1992 ·Infection Control and Hospital Epidemiology ·Robert A. Weinstein, (unknown), Elías Abrutyn, (unknown), Donald E. Craven, Boston, John M. Boyce, (unknown), Loreen A. Herwaldt, (unknown), Peter Groß, C. G. Mayhall, (unknown), (unknown), Ludwig A. Lettau, (unknown), William Martone, (unknown), (unknown), (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact